SpringWorks Therapeutics Inc (NAS:SWTX)
$ 34.76 1.66 (5.02%) Market Cap: 2.58 Bil Enterprise Value: 2.08 Bil PE Ratio: 0 PB Ratio: 4.63 GF Score: 40/100

SpringWorks Therapeutics Inc Clinical Trials Transcript

Oct 13, 2020 / NTS GMT
Release Date Price: $59.22 (+1.89%)
Jeannie Gordon;Uche Iloeje
NF Network - Moderator;SpringWorks Therapeutics, Inc. - VP, Medical

Good afternoon, everyone. I'm Jeannie Gordon. I'd like to welcome you to this presentation by Dr. Uche Iloeje on NF clinical trials.

Dr. Iloeje is the Vice President for Medical Affairs of SpringWorks Therapeutics, a biopharmaceutical company. He received his medical training in Nigeria and at the University of Pittsburgh as well as Yale. He has two decades of experience in the pharmaceutical industry, and he enjoys working with patient organizations like the NF Network.

He will educate us today on the clinical trial process and what is in the pipeline for NF patients. We are very grateful that he is sharing his knowledge with us this afternoon.

Dr. Iloeje will leave time after this presentation to answer questions. So please leave them in the Q&A box, and that should be on the bottom of your screen. We'll do your best to get to all of them -- our best to get to all of them so -- during the next hour. I'd like to pass this on to Dr. Iloeje now.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot